Robin Smith is no longer serving in their board position at Seelos Therapeutics, Inc.

Jun 01, 2020
Board and Executive Moves
Background Information
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio includes late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.